Literature DB >> 1607035

Dermatofibrosarcoma protuberans: treatment and prognosis.

E J Rutgers1, B B Kroon, C E Albus-Lutter, E Gortzak.   

Abstract

Dermatofibrosarcoma protuberans (DFSP) is a rare tumor of the skin with a strong tendency to recur locally. Nineteen cases of DFSP are presented. In eight of them a total of 20 local recurrences occurred, in five after irradical and in three after 'narrow' excisions. After wide excision (greater than 2 cm) for primary or wide re-excision for recurrent tumor, all patients remained free of tumor with a mean follow-up of 13.2 years (range 2-28 years). An extensive literature review revealed 913 cases of DFSP. The overall recurrence rate is about 50%; after adequate wide excision, 13%. Recurrent tumor is safely treated by wide re-excision and the recurrence rate is then 12%. Regional and distant recurrences are infrequent. Eleven cases (1%) were reported to have regional lymph node metastases and 37 (4%, 17 of whom were histologically confirmed) distant metastases, principally in the lung. The prognosis after appearance of regional or distant recurrence is bad. The role of radiotherapy in the management of this tumor is unclear. Primary or recurrent DFSP is best treated by surgical excision with a minimal margin of 2- preferably 3-cm of surrounding skin including the underlying fascia. Elective lymph node dissection is not advised.

Entities:  

Mesh:

Year:  1992        PMID: 1607035

Source DB:  PubMed          Journal:  Eur J Surg Oncol        ISSN: 0748-7983            Impact factor:   4.424


  44 in total

1.  Dermatofibrosarcoma presenting as a nodule in the breast of a 75-year-old woman: a case report.

Authors:  Olivier Cottier; Maryse Fiche; Jean-Yves Meuwly; Jean-François Delaloye
Journal:  J Med Case Rep       Date:  2011-10-05

2.  Establishment and characterization of NCC-DFSP3-C1: a novel patient-derived dermatofibrosarcoma protuberans cell line.

Authors:  Yuki Yoshimatsu; Rei Noguchi; Ryuto Tsuchiya; Akane Sei; Makoto Nakagawa; Akihiko Yoshida; Akira Kawai; Tadashi Kondo
Journal:  Hum Cell       Date:  2020-04-30       Impact factor: 4.174

Review 3.  Targeted therapy for dermatofibrosarcoma protuberans.

Authors:  Thomas A Abrams; Scott M Schuetze
Journal:  Curr Oncol Rep       Date:  2006-07       Impact factor: 5.075

4.  Dermatofibrosarcoma Protuberans-Like Tumor With COL1A1 Copy Number Gain in the Absence of t(17;22).

Authors:  Jad Saab; Ian M Rosenthal; Lu Wang; Klaus J Busam; Kishwer S Nehal; Mark A Dickson; Meera R Hameed; Travis J Hollmann
Journal:  Am J Dermatopathol       Date:  2017-04       Impact factor: 1.533

5.  Dermatofibrosarcoma Protuberans Male Breast: A Case report.

Authors:  Tahir Iqbal Mirza; Kaleem Akhtar; Hussan Burair Abbas; Mubashra Sameena; Fasiha Tahir; Saleem Khan; Akeel Ur Rehman Bhutto
Journal:  Oman Med J       Date:  2011-09

6.  Dermatofibrosarcoma protuberans: Our experience of 59 cases.

Authors:  Alessio Stivala; Giuseppe A G Lombardo; Gianluca Pompili; Maria Stella Tarico; Filippo Fraggetta; Rosario Emanuele Perrotta
Journal:  Oncol Lett       Date:  2012-08-30       Impact factor: 2.967

Review 7.  Dermatofibrosarcoma protuberans with fibrosarcomatous transformation of the head and neck.

Authors:  Nikolaos Angouridakis; Panagiotis Kafas; Waseem Jerjes; Stefanos Triaridis; Tahwinder Upile; Georgios Karkavelas; Angelos Nikolaou
Journal:  Head Neck Oncol       Date:  2011-02-04

8.  [Recurrent fibrosarcomatous dermatofibrosarcoma protuberans. Ultrasound imaging].

Authors:  K J Kilian; T Ruzicka; M Flaig; C Berking; C Kunte
Journal:  Hautarzt       Date:  2013-07       Impact factor: 0.751

Review 9.  Current treatment options in dermatofibrosarcoma protuberans.

Authors:  Doreen Lemm; L-O Mügge; T Mentzel; K Höffken
Journal:  J Cancer Res Clin Oncol       Date:  2009-02-10       Impact factor: 4.553

10.  Imatinib in the treatment of dermatofibrosarcoma protuberans.

Authors:  Stefanos V Labropoulos; Evangelia D Razis
Journal:  Biologics       Date:  2007-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.